Starting on:
Oct 1, 2026
Ending on:
Oct 1, 2026
Moderator(s):
Eka hotel, eldoret
Max Credits:
3 Points
Provider:
OAK TREE CENTRE FOR KIDNEY AND CHRONIC DISEASES
Claim Points
Oct 1, 2026
Ending on:
Oct 1, 2026
Moderator(s):
Dr.
Daisy Korir
Consultant physician
Venue: Consultant physician
Eka hotel, eldoret
Max Credits:
3 Points
Provider:
OAK TREE CENTRE FOR KIDNEY AND CHRONIC DISEASES
Claim Points
The anticoagulation landscape: Does the choice of DOAC matter
Starting on:
Oct 1, 2026
Oct 1, 2026
Ending on:
Oct 1, 2026
Oct 1, 2026
Venue:
Eka hotel, eldoret
Eka hotel, eldoret
Description
This session will explore the role of direct oral anticoagulants (DOACs) in the prevention and treatment of thromboembolic disease, with emphasis on selecting the most appropriate agent for individual patients.
Objectives
Compare the mechanisms of action, indications, efficacy, and safety profiles of available DOACs.
Select an appropriate DOAC based on patient characteristics, renal function, comorbidities, and thromboembolic risk.
Evaluate anticoagulation options in complex clinical scenarios, including cancer-associated thrombosis, renal impairment, and high bleeding risk.
Presenters
-
Dr.
Constantine Akwanalo
Consultant Cardiologist
Moi Teaching and Referral Hospital and Department of Medicine, Moi University